Cortagen 20mg

What it is

Cortagen is a short peptide described as a peptide bioregulator in the scientific literature. This terminology relates to its study in biological systems, rather than an established clinical effect in people.

The Welcuren presentation is a branded pre-filled pen with a protective case. The 20mg designation identifies the product strength, not an individual prescribing recommendation. Supply through our licensed facility does not mean that Cortagen itself has a UK marketing authorisation.

Why people ask about it

People may ask about Cortagen after encountering discussions of peptide bioregulators, cognitive wellbeing or healthy ageing. Interest in these areas should not be confused with evidence that Cortagen improves memory, concentration or lifespan.

Our clinicians provide a measured assessment of the available literature, your reasons for enquiring and the uncertainties involved. A consultation does not guarantee a prescription.

What the science says

The available literature is largely based on laboratory and animal investigations. Such work may explore biological activity, but it cannot establish meaningful outcomes or an acceptable safety profile in humans. Evidence concerning other peptide bioregulators should not be presented as evidence for Cortagen.

Reliable human data on clinical outcomes, interactions and long-term exposure remain insufficient. Published findings also do not necessarily establish the quality, stability or performance of a particular branded pen. Cortagen is not a UK-licensed medicine, and any prescribing requires a separate clinical assessment of whether an unlicensed option is appropriate.

Is it right for me?

This service is for adults aged 18 and over. Cortagen is not suitable during pregnancy or breastfeeding, or for anyone with a known allergy to its ingredients. If you are trying to conceive, this should be discussed with our clinicians before any prescribing decision.

A current or previous cancer diagnosis requires particular caution and may rule out prescribing; adequate safety evidence in this group is lacking. Significant medical conditions, ongoing investigations and all medicines and supplements must be disclosed. Our clinicians may decline prescribing or recommend assessment by your usual healthcare professional.

How Welcuren works

Complete a short online consultation about your health and goals.

A clinician reviews your answers, may ask follow-up questions, and decides whether this treatment is appropriate for you.

You only pay once treatment is approved. Our licensed facility then dispatches it with full instructions, on tracked global delivery.

Safety

Cortagen’s side-effect profile is not well characterised in humans, and reliable frequencies are unavailable. Possible risks include local discomfort, redness or swelling, and allergic reactions to the peptide or other ingredients. Unreported adverse effects and interactions are also possible; limited published safety data should not be interpreted as reassurance.

Our clinicians review your medical history and discuss appropriate follow-up and monitoring before prescribing. Monitoring cannot remove the uncertainties associated with an unlicensed product. Report unexpected symptoms promptly, and seek urgent medical attention for breathing difficulty, facial swelling or other signs of a severe allergic reaction.